Friday Aug 15
OTC Product News
NEXIUM 24HR Marketed by: Pfizer Consumer Healthcare Pfizer Inc has introduced Nexium 24HR, an OTC treatment for frequent heartburn.
Thu Aug 14, 2014
Esomeprazole Treatment of Frequent Heartburn: Two Randomized, Double-Blind, Placebo-Controlled Trials
Log in or subscribe to view full content. Article is also available for purchase the article in one of the available formats.
Wed Aug 13, 2014
POZEN Reports Second Quarter 2014 Results
Royalty revenue from VIMOVO for Q2 2014 was over Q2 of 2013. POZEN announced that the resubmission of the New Drug Application for PA8140/PA32540 was submitted to the compared to Q2 2013.
Horizon Pharma Announces U.S. Patent and Trademark Office Issuance of ...
"The claims included in this Notice of Allowance continue to expand the strength of the VIMOVO patent estate and add to our ability to protect VIMOVO innovation in the U.S. and to continue to make this important therapy available to patients," stated Timothy P. Walbert, chairman, president and chief executive officer, Horizon Pharma.
Fri Aug 08, 2014
FTC v. Actavis, Inc.
Case Name: FTC v. Actavis, Inc. , Case No. 1:09-CV-955-TWT, 2014 U.S. Dist. LEXIS 54808 Nature of the Case and Issue Presented: In FTC v.
Tue Aug 05, 2014
Horizon Pharma Announces the U.S. Patent and Trademark Office...
"The claims included in these Notices of Allowance further bolster the already robust VIMOVO patent estate," stated Timothy P. Walbert, chairman, president and chief executive officer, Horizon Pharma.
Mon Aug 04, 2014
AIDS Research and Therapy
Therapeutic drug monitoring of voriconazole: a case report of...
Voriconazole is metabolized by cytochrome P450 2C19 and CYP 3A4. Drug-drug interactions and genetic polymorphisms modulate their activities.
Rascal Flatts Joins the Thousands of People Who Choose Nexium 24HR...
Starting today, consumers can learn more about the guarantee and high value offer at Nexium24HR.com .